User profiles for Dušek Petr
Petr DušekDepartment of Neurology and Center of Clinical Neuroscience, Charles University, 1st … Verified email at vfn.cz Cited by 5480 |
[HTML][HTML] Trial of deferiprone in Parkinson's disease
Background Iron content is increased in the substantia nigra of persons with Parkinson’s
disease and may contribute to the pathophysiology of the disorder. Early research suggests that …
disease and may contribute to the pathophysiology of the disorder. Early research suggests that …
Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder
…, NJ Diederich, K Doppler, P Dušek… - The Lancet …, 2021 - thelancet.com
Patients with isolated rapid-eye-movement sleep behaviour disorder (RBD) are commonly
regarded as being in the early stages of a progressive neurodegenerative disease involving α…
regarded as being in the early stages of a progressive neurodegenerative disease involving α…
Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: a multicentre study
The neurodegenerative synucleinopathies, including Parkinson’s disease and dementia
with Lewy bodies, are characterized by a typically lengthy prodromal period of progressive …
with Lewy bodies, are characterized by a typically lengthy prodromal period of progressive …
Speech biomarkers in rapid eye movement sleep behavior disorder and Parkinson disease
Objective This multilanguage study used simple speech recording and high‐end pattern
analysis to provide sensitive and reliable noninvasive biomarkers of prodromal versus manifest …
analysis to provide sensitive and reliable noninvasive biomarkers of prodromal versus manifest …
Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension …
…, C Küpper, C Neuhofer, B Kálmán, P Dušek… - The Lancet …, 2019 - thelancet.com
Background Pantothenate kinase-associated neurodegeneration (PKAN) is a rare genetic
disorder characterised by progressive generalised dystonia and brain iron accumulation. We …
disorder characterised by progressive generalised dystonia and brain iron accumulation. We …
Smartphone allows capture of speech abnormalities associated with high risk of developing Parkinson's disease
Although smartphone technology provides new opportunities for the recording of speech
samples in everyday life, its ability to capture prodromal speech impairment in persons with a …
samples in everyday life, its ability to capture prodromal speech impairment in persons with a …
Pathogenesis of Wilson disease
IF Scheiber, R Brůha, P Dušek - Handbook of clinical neurology, 2017 - Elsevier
… Author links open overlay panel Ivo Florin Scheiber 1 , Radan Brůha 2 , Petr Dušek 3 … et al.,
2013); however, the clinical consequences of these findings are unclear (Dusek et al., 2015). …
2013); however, the clinical consequences of these findings are unclear (Dusek et al., 2015). …
Automated speech analysis in early untreated Parkinson's disease: Relation to gender and dopaminergic transporter imaging
…, D Zogala, E Růžička, P Dušek - European journal of …, 2022 - Wiley Online Library
Background The mechanisms underlying speech abnormalities in Parkinson's disease (PD)
remain poorly understood, with most of the available evidence based on male patients. This …
remain poorly understood, with most of the available evidence based on male patients. This …
[HTML][HTML] The subthalamic microlesion story in Parkinson's disease: electrode insertion-related motor improvement with relative cortico-subcortical hypoactivation in …
Electrode implantation into the subthalamic nucleus for deep brain stimulation in Parkinson's
disease (PD) is associated with a temporary motor improvement occurring prior to …
disease (PD) is associated with a temporary motor improvement occurring prior to …
Deep brain stimulation of the subthalamic nucleus affects resting EEG and visual evoked potentials in Parkinson's disease
OBJECTIVE: We studied changes of the EEG spectral power induced by deep brain stimulation
(DBS) of the subthalamic nucleus (STN) in patients with Parkinson's disease (PD). Also …
(DBS) of the subthalamic nucleus (STN) in patients with Parkinson's disease (PD). Also …